Which group of individuals is in the best position to spot early warning signs of economic trouble? There's a good case to be ...

On April 6, the sun's sextile to lucky Jupiter marks the perfect moment for taking chances, expanding your horizons and ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

Astrologer Lisa Stardust reveals what each zodiac sign can expect in their careers, relationships and lives when the 4/4 ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...

We recently published a list of Jim Cramer Looked At These 23 Stocks Recently. In this article, we are going to take a look ...

Google AI Studio is a cloud-based development environment designed for working with Gemini, Google's next-generation ...

Is it just me, or is "What's your birth chart?" the new "What do you like to do in your free time?" Birth charts have become ...

On CNBC's “Halftime Report Final Trades ,” Jim Lebenthal of Cerity Partners said he is long-term bullish but a bit nervous ...

Vertex Pharmaceuticals (VRTX) closed the latest trading day at $512.52, indicating a +0.06% change from the previous session's end. The stock's change was less than the S&P 500's daily gain of 1.08%.

Vertex Inc. (NASDAQ:VERX) ("Vertex” or the "Company”), a global provider of indirect tax technology solutions, reveals that ...